Clinical trials
Gastric clinical trials
Below are recruiting gastric clinical trials, each written for real people, not researchers. We’re tracking 860 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06506825Recruiting
Stomach Cancer Database Study Using Artificial Intelligence
This trial is building a large database of stomach cancer patients using artificial intelligence to better understand the disease. If you have stomach cancer, you may be able to join and help improve future care.
Shijiazhuang, HebeiAges 18 years+ - NCT07532915Recruiting
Two endoscopy methods to prevent stomach vein bleeding
This trial compares two endoscopic (camera-guided) procedures to prevent or treat bleeding from enlarged veins in the stomach. Both approaches aim to stop dangerous bleeding or prevent it from happening in high-risk patients.
Guangzhou, GuangdongAges 18–80 - NCT07038148Recruiting
Single-stage conversion of gastric bypass to sleeve gastrectomy
This trial is testing a single surgery that converts a previous gastric bypass into a sleeve gastrectomy, and checking if there is a higher risk of leaks. It may be an option for people who need this change and are in good overall health.
Cairo, Old CairoAges 18–70 - NCT06478394Recruiting
Blood test for hidden stomach cancer spread
This study tests a new blood test that uses machine learning to find hidden stomach cancer spread (peritoneal metastases) early. It could help people with locally advanced stomach cancer avoid unnecessary surgery.
Shijiazhuang, HebeiAges 18 years+ - NCT06943781Recruiting
Gastric cancer screening using high-risk gene detection
This trial is testing a new way to identify people at higher risk for stomach cancer using a gene test for Helicobacter pylori. It may help detect cancer early in people aged 40 and older.
TonglingAges 40 years+ - NCT06727981Recruiting
Immunotherapy as first treatment for stomach cancer
This trial tests immunotherapy as the first treatment for people with advanced or locally advanced stomach cancer. It may help if you haven't had any prior anti-cancer therapy and are starting treatment soon.
Jinan, ShandongAges 18–100 - NCT07327229RecruitingPhase 1/Phase 2
Study of ATG-022 plus pembrolizumab for stomach or GEJ cancer
This trial tests a new drug combo (ATG-022 plus pembrolizumab, with or without chemo) for people with advanced stomach or gastroesophageal junction cancer that has a specific protein (CLDN 18.2) and is HER2-negative and PD-L1-positive. It may be an option if you have not had certain prior treatments.
Hefei, AnhuiAges 18 years+ - NCT07237126Recruiting
Single-port robotic surgery for stomach cancer
This trial is testing a newer, less invasive robotic surgery technique that uses just one small incision to remove stomach cancer. It may offer faster recovery and less pain compared to traditional surgery.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT06901531RecruitingPhase 3
Study of zolbetuximab with pembrolizumab and chemo for gastric cancer
This trial tests a new combination of drugs (zolbetuximab, pembrolizumab, and chemotherapy) for people with advanced stomach or gastroesophageal junction cancer. It may be an option if your tumor has certain proteins (CLDN18.2 and PD-L1) and you haven't had chemotherapy for advanced disease.
Birmingham, AlabamaAges 18 years+ - NCT07724496Recruiting
H. pylori and stomach growth features study
This study looks at whether having H. pylori infection (a common stomach bacteria) and certain features of stomach growth can predict how early stomach cancer or pre-cancerous changes will behave and what your long-term outlook might be. You may be eligible if you are being treated with a camera-based removal procedure called endoscopic submucosal dissection (ESD).
Beijing, Beijing MunicipalityAges 18–80 - NCT03821636Recruiting
Compare gastric bypass limb lengths for type 2 diabetes remission
This study looks at whether a gastric bypass surgery with a longer intestine segment or a longer bile drainage segment leads to better type 2 diabetes remission in people with severe obesity. It may help doctors choose the most effective surgical approach and follow-up plan for diabetes improvement.
AmiensAges 18–60 - NCT03900910Recruiting
Gastric cancer prevention program for Indigenous adults
This trial studies a prevention approach to help lower the chance of stomach (gastric) cancer in Indigenous people. You may be able to join if you’re in the right age range, can understand consent, and are not pregnant or dealing with serious other illnesses.
Taipei, TaiwanAges 20–60 - NCT03972956Recruiting
Collecting samples during cancer or surgery visits
This trial looks at collecting (taking) medical samples from people who need surgery for colorectal cancer, stomach (gastric) cancer, or a non-cancer condition. It may help researchers better understand these diseases and improve how treatment is planned.
Wuhan, HubeiAges 18–80 - NCT04022109Recruiting
Check gastric cancer using breath chemical signals
This study looks at chemical signals in your breath to help screen for or understand gastric (stomach) cancer. It may help doctors improve earlier detection, or better sort out who may need further tests.
São PauloAges 18 years+ - NCT04191551Recruiting
Study of stomach precancer conditions during endoscopy
This study looks at people with certain stomach symptoms or precancer risk factors when they get a camera test of the upper digestive tract (endoscopy). The goal is to learn how to better detect and evaluate stomach precancer conditions early, which may help guide treatment or follow-up.
Stanford, CaliforniaAges 35–84 - NCT04214990RecruitingPhase 3
Aspirin after early stomach precancer or early cancer removal
This trial tests whether taking aspirin after endoscopic removal of an early stomach condition can lower the chance of the cancer coming back or progressing. You may be considered if your early stomach findings were fully removed and you’re able to avoid certain medications that raise bleeding risk.
BusanAges 19–70 - NCT04422405Recruiting
One-anastomosis stomach bypass study for reflux and stomach changes
This study looks at how a one-anastomosis gastric bypass changes how your stomach and esophagus work, especially relating to acid reflux. You may be offered the planned surgery if you fit the weight and heartburn/reflux-related conditions, and the team will measure changes before and after.
Schlieren, Canton of ZurichAges 18–65 - NCT04812132Recruiting
Compare two types of weight-loss stomach surgery
This study compares two surgical methods used for weight loss: OAGB and a longer-limb Roux gastric bypass. It may help find which option works best for people with severe obesity and obesity-related health problems.
TartuAges 18–60 - NCT04894838Recruiting
Testing a bypass revision surgery for weight regain
This study looks at whether a specific stomach bypass revision (a “distal gastric bypass”) can improve outcomes after Roux-en-Y gastric bypass when weight loss was not enough or weight was regained. You may be considered if you meet weight-loss goals criteria and can join follow-up and possibly surgery.
Arnhem, GelderlandAges 18–65 - NCT05320796RecruitingPhase 4
Esomeprazole study after gastric bypass and pouch acid levels
This trial tests how well esomeprazole (a acid-reducing medicine) works after a Roux-en-Y gastric bypass, and how it changes the acidity in the stomach pouch. It may help confirm the best way to control stomach acid after bypass surgery.
Schlieren, SchlierenAges 18 years+ - NCT05514769Recruiting
Surgery type comparison for early-to-mid stomach cancer
This trial compares two different stomach cancer surgeries after removing the tumor, to see which works better for patients with stomach adenocarcinoma. It may help determine the safest approach and best recovery outcomes for people whose cancer has not spread.
Nanchong, SichuanAges 18–85 - NCT05640947Recruiting
Procedure to reverse bypass using an endoscopic stent
This trial studies a minimally invasive procedure that uses a stent placed through an endoscope to create a new connection in the stomach, with the goal of reversing a Roux-en-y gastric bypass. It may help people whose bypass has led to nutrition problems, severe dumping symptoms, difficult marginal ulcers, or liver scarring that worsens after surgery.
BrugesAges 18 years+ - NCT05723718Recruiting
Testing body-water measurements in people with stomach cancer
This trial uses a painless machine to measure your body composition (mainly fluid and muscle) using bioelectrical impedance. It’s looking at people with stage II–III stomach cancer who are receiving standard “multi-treatment” care, to see whether these measurements are useful during treatment.
LublinAges 18–100 - NCT05728242Recruiting
Gastric ultrasound to guide anesthesia for fracture surgery
This trial studies using a bedside ultrasound scan of the stomach (“gastric ultrasound”) to help guide anesthesia decisions during surgery for traumatic fractures. It may help reduce stomach-related anesthesia risks in the operating room by better assessing stomach contents.
IstanbulAges 18–90
Hear when a new Gastric trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for gastric?
- Yes. Clin2 currently lists 860 recruiting gastric studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a gastric trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a gastric trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.